PracticeUpdate Dermatology Best of 2018

LIFE IS HARSH ON THE SKIN THEY’RE IN In eczema-prone skin, key components of the skin’s barrier layer, the ceramides, are reduced. 1 Research has shown that the addition of ceramides can help reinforce the skin’s barrier layer, 2 while ingredients such as lactic acid and niacinamide may contribute to supporting the skin, promoting ceramide synthesis from the stratum corneum. 3,4

The new QV Intensive with Ceramides range has been specially formulated to help manage eczema-prone skin through its unique dual action: Delivering ceramides and providing lactic acid and niacinamide topically to the skin, helping change the landscape of eczema-prone skin.

References: 1. Hon K.L, Leung K.C and Barankin B. Barrier Repair Therapy in Atopic Dermatitis: An Overview. Am J Clin Dermatol. 2013; 14:389-399. 2. Di Nardo A, Wertz P, Giannetti A, Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol. 1998; 78(1):27-30. 3. Rawlings AV, Davies A, Carlomusto M, Pillai S, Zhang K, Kosturko R, et al. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res. 1996; 288:383– 390. 4. Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Brit J Dermatol. 2000; 143:524–531. EGO PHARMACEUTICALS PTY LTD. 21-31 Malcolm Road, Braeside, 3195, Australia. australia +61 3 9586 8800 toll free 1800 033 706. ‘Ego’ and ‘QV’ are trademarks of Ego Pharmaceuticals Pty Ltd in Australia and other countries. ©2018 Ego. www.qvskincare.com.au ask@egopharm.com www.egopharm.com EGOPSH0230 09/18 S&H